Literature DB >> 27033172

Dyslipidemia and its risk factors among urban middle-aged Iranians: A population-based study.

Hossein Ebrahimi1, Mohammad Hassan Emamian2, Hassan Hashemi3, Akbar Fotouhi4.   

Abstract

AIMS: Dyslipidemia is a known risk factor for cardiovascular disease and is a leading cause of mortality in developed and developing countries. This study was aimed to determine the prevalence of dyslipidemia and its risk factors in an urban group of Iranian adult population.
METHODS: In this study, based on the criteria set by the National Cholesterol Education Program, the prevalence of dyslipidemia was evaluated in a population of 4737 people aged 45-69 years who participated in the second phase of an ophthalmology cohort study in Shahroud. Dyslipidemia prevalence was determined by age, sex, and risk factors of the disease; the findings were tested by using simple and multiple logistic regression.
RESULTS: The prevalence of dyslipidemia was 66.5% (CI 95%: 64.4-68.6) in males, 61.3% (CI 95%: 59.5-63.2) in females, and 63.4% (CI 95%: 62.0-64.9%) in both sexes. The prevalence of hypertriglyceridemia, hypercholesterolemia, low HDL-C, and high LDL-C, respectively, was 28.8%, 13.4%, 42.3%, and 13.4%, respectively. In multivariate logistic regression model, increase of age (for females), abdominal obesity, overweight and obesity, hypertension, and diabetes were associated with an increased odd of dyslipidemia.
CONCLUSION: The prevalence of dyslipidemia in middle-aged urban population in Iran is high, and with increasing age there is an increased risk of dyslipidemia. Hence, considering the growing trend of aging in Iran, there is need for taking special measures to deal with dyslipidemia as a health priority. Furthermore, the need for planning in order to reduce the risk of dyslipidemia and prevent its complications is greater than ever.
Copyright © 2016 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dyslipidemia; Iran; Population-based study; Prevalence; Risk factor

Mesh:

Year:  2016        PMID: 27033172     DOI: 10.1016/j.dsx.2016.01.009

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  7 in total

1.  Prevalence of dyslipidemia and its association with opium consumption in the Rafsanjan cohort study.

Authors:  Zahra Jamali; Mojgan Noroozi Karimabad; Parvin Khalili; Tabandeh Sadeghi; Ahmadreza Sayadi; Faegheh Mohammadakbari Rostamabadi; Carlo La Vecchia; Ali Esmaeili-Nadimi
Journal:  Sci Rep       Date:  2022-07-07       Impact factor: 4.996

2.  Association between dyslipidemia and blood lipids concentration with smoking habits in the Kurdish population of Iran.

Authors:  Mehdi Moradinazar; Yahya Pasdar; Farid Najafi; Soodeh Shahsavari; Ebrahim Shakiba; Behrooz Hamzeh; Negin Fakhri
Journal:  BMC Public Health       Date:  2020-05-13       Impact factor: 3.295

3.  Modeling the risk factors for dyslipidemia and blood lipid indices: Ravansar cohort study.

Authors:  Mansour Rezaei; Negin Fakhri; Yahya Pasdar; Mehdi Moradinazar; Farid Najafi
Journal:  Lipids Health Dis       Date:  2020-07-28       Impact factor: 3.876

4.  Joint effects of self-reported sleep and modifiable physical activity on risk of dyslipidaemia in women aged 45-55 years: a cross-sectional study.

Authors:  Sha Du; Yuenan Su; Dongxue Zhang; Jing Wu; Huiqiu Zheng; Xuemei Wang
Journal:  BMJ Open       Date:  2022-01-07       Impact factor: 2.692

5.  Effects of Body Mass Index, Waist Circumference, Waist-to-Height Ratio and Their Changes on Risks of Dyslipidemia among Chinese Adults: The Guizhou Population Health Cohort Study.

Authors:  Li Cao; Jie Zhou; Yun Chen; Yanli Wu; Yiying Wang; Tao Liu; Chaowei Fu
Journal:  Int J Environ Res Public Health       Date:  2021-12-29       Impact factor: 3.390

6.  Associations between age and dyslipidemia are differed by education level: The Cardiovascular and Metabolic Diseases Etiology Research Center (CMERC) cohort.

Authors:  So Mi Jemma Cho; Ho Jae Lee; Jee Seon Shim; Bo Mi Song; Hyeon Chang Kim
Journal:  Lipids Health Dis       Date:  2020-01-18       Impact factor: 3.876

7.  Level of Control of Dyslipidemia Among Patients Followed in Family Medicine Clinics in Riyadh, Saudi Arabia.

Authors:  Amal Hadi; Mohammed A AlAteeq
Journal:  Cureus       Date:  2021-06-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.